Thomas Marko & Associés supports the promotion of two iconic brands from Sanofi's Consumer Healthcare division
Following a consultation process, Sanofi, theleading French and European pharmaceutical group, selects Thomas Marko & Associés to develop and implement the influence and media relations strategy for two flagship brands in its Consumer Health Care division: Phytoxil® and Novanuit®. The agency will also manage Phytoxil®'s social media activities. With this collaboration, Thomas Marko & Associés once again demonstrates its expertise in healthcare communications.
Phytoxil® and Novanuit®, partners of the Paris 2024 Olympic and Paralympic Games, in the service of well-being
Sanofi, through its Consumer Healthcare division, offers a wide range of innovative products and medicines designed to improve everyday well-being. Phytoxil®, a brand of cough syrups, is recognized and recommended by pharmacists* for its medical devices based on plant extracts, active ingredients of plant origin or molecules of natural origin to relieve coughs and soothe irritated throats. Novanuit®, for its part, is dedicated to improving sleep quality through its dietary supplements, which incorporate melatonin and plant extracts to facilitate falling asleep, improve sleep and promote restful rest.
As official partners of the Paris 2024 Olympic and Paralympic Games, these two brands will benefit from exceptional exposure, conducive to reinforcing their image of proximity and trust with consumers.
Thomas Marko & Associés is therefore part of a long-term strategic move to position Phytoxil® and Novanuit® as key players in everyday well-being, through a prestigious partnership with the most eagerly-awaited sporting event of the decade.
* Kantar Panel Healthcare self-medication survey of 8,000 adults from October 2020 to September 2022.